THE SIGNIFICANCE OF ADVANCED TECHNOLOGICAL PROCESSES IN TAILORING STENTS FOR OPTIMAL BIOCOMPATIBILITY
Main Article Content
Abstract
Abstract: Cardiovascular diseases (CVD) continue to be a major global health concern, with coronary heart disease (CHD) being a leading contributor. In recent years, 3D printing technologies have demonstrated their potential to revolutionize the field of cardiovascular medicine, particularly in the development of implantable bioresorbable drug-eluting scaffolds, commonly known as stents. This article provides an in-depth review of the profound impact of 3D printing on the fabrication of bioresorbable stents, highlighting the ability to customize and personalize these devices to address longstanding challenges associated with stenting. The article also discusses materials with the necessary properties for 3D printing, regulatory considerations, and offers expert insights into the future directions of this transformative technology.
Article Details
References
Yusupov, S. A. U. (2022). Ways to improve the effectiveness of orthodontic treatment in bukhara region to prevent the development of caries. Central Asian Research Journal for Interdisciplinary Studies (CARJIS), 2(3), 457-464.
Ugli, Y. S. A. (2022). The Effectiveness of Rehabilitation Centers on the Psych emotional State of Children of the First Period of Childhood with Congenital Cleft Lip and Palate. Eurasian Medical Research Periodical, 7, 212-214.
Xuseynovna, K. S. A. (2022). Optimization of the Diagnosis and Treatment of Oral Epulis Based on Morphological and Cytological Analysis. Texas Journal of Medical Science, 6, 24-26.
Khalaj, R., Tabriz, A. G., Okereke, M. I., & Douroumis, D. (2021). 3D printing advances in the development of stents. International Journal of Pharmaceutics, 609, 121153.
Pulatova, S. K., & Yusupov, S. A. (2020). ENHANCEMENT TREATMENTS OF METHODS OF RADICULAR CYSTS OF JAW. Theoretical & Applied Science, (5), 337-340.
Navruzova, U. O., Khamidova, N. Q., & Yusupov, S. H. (2019). A. Featurus of Periodontitis in Metabolo c Disorders. European journal of pharmaceutical and medical research, 3, 108-113.